Overall Health Care Spending
Testimony to Congress from CAHC’s J.P. Wieske: House Energy and Commerce Health Subcommittee Hearing on March 6, 2019
Letter to Senate HELP Chairman Lamar Alexander: Response to Request for Stakeholder Input on Solutions to Lower Health Costs - March 1, 2019
Letter to House Leadership: CAHC’s Vision for Meaningful Reforms that Lower Health Costs for all Americans - June 10, 2016
Health Care Spending and Prescription Drugs
Letter to HHS Inspector General on proposed rebate rule - April 2019
Coalition letter to President Trump and Members of Congress against drug reimportation - April 2019
Letter to CMS: CAHC writes in opposition to the administration’s proposed International Pricing Index for Part B treatments - December 2018
Coalition Letter to HHS opposing International Pricing Index for Part B treatments - November 2018
Letter to FDA Commissioner Scott Gottlieb opposing drug importation workgroup - October 2018
Letter to HHS Secretary Alex Azar: CAHC responds to the Trump administration’s “American Patients First” blueprint for improving prescription drug affordability - July 2018.
Letter to President Trump: Improving prescription drug access and affordability through value-based payment arrangements (VBAs) - April 2018.
Letter to the Senate HELP Committee on Prescription Drug Costs - December 2017
Infographic: Drug Competition Creates Lower Drug Prices- Infographic - March 2016
Letter to Senators Wyden and Grassley: Request for Information on Policy Issues Including the Financial Impact of High Prices of Breakthrough Drugs, Ensuring Patient Access, and Improving Marketplace Transparency - March 2016